Ticker Details
PTC Therapeutics, Inc. PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.
IPO Date:	June 20, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$5.71B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.87 | 2.62%
Avg Daily Range (30 D):	$1.13 | 1.60%
Avg Daily Range (90 D):	$1.08 | 1.53%

Institutional Daily Volume
Avg Daily Volume:	.74M
Avg Daily Volume (30 D):	.99M
Avg Daily Volume (90 D):	.87M

Trade Size
Avg Trade Size (Sh.):	87
Avg Trade Size (Sh.) (30 D):	59
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	7,949
Avg Institutional Trade:	$2.95M
Avg Institutional Trade (30 D):	$7.2M
Avg Institutional Trade (90 D):	$6.11M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.09M
Avg Closing Trade (30 D):	$17.52M
Avg Closing Trade (90 D):	$16.32M
Avg Closing Volume:	114.57K

News

Dec 31, 2025 @ 3:47 PM What's Going On With Royalty Pharma Stock Wednesda... Source: Vandana Singh

Dec 29, 2025 @ 9:40 PM Royalty Pharma Acquires Remaining Royalty Interest... Source: Globe Newswire

Sep 5, 2025 @ 12:35 PM Here's Why Shares in PTC Therapeutics Soared This ... Source: Lee Samaha

Jul 17, 2025 @ 5:00 AM Novartis reports strong Q2 with double-digit sales... Source: Novartis

Jun 2, 2025 @ 5:55 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.48	$-.03	$-1.82
Diluted EPS	$-2.33	$-.03	$-1.67
Revenue	$827.11M	$272.55M	$164.68M
Gross Profit
Net Income / Loss	$-186.73M	$-2.81M	$-134.97M
Operating Income / Loss	$-58.33M	$44.96M	$-71.35M
Cost of Revenue
Net Cash Flow	$-661.22M	$-146.38M	$302.24M
PE Ratio